Effectiveness of direct delabelling of allergy labels in type A adverse drug reactions to penicillin: a multicentre hospitalwide prospective cohort study.

Kate Drummond Sara VogrinBelinda LambrosJason A Trublano Elise Mitri

Published in: The Journal of antimicrobial chemotherapy (2024)

Both direct delabelling and DOC of type A ADR PALs increased penicillin usage; however, the impact was greatest with DOC. Most patients remain delabelled at 90 days.

Keyphrases

adverse drug
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
systematic review
clinical trial
peritoneal dialysis
emergency department
cross sectional
infectious diseases